Article Name Clinical & Diagnostic
Next-Generation INTERCEPT Blood Safety Device Receives Multiple International Regulatory Clearances for Broader Adoption.
29th May, 2025
Amid a former President’s diagnosis, breakthrough technology offers earlier, more accurate detection—raising urgent questions about systemic delays in adoption
28th May, 2025
Milestone highlights growing clinical adoption of AI-powered, non-invasive technology for early melanoma diagnosis.
28th May, 2025
European regulatory approval paves the way for Dermalyser’s clinical rollout, enhancing early skin cancer diagnosis through advanced AI technology.
27th May, 2025
Groundbreaking non-active implant for acid reflux draws global attention and fuels U.S. clinical engagement at world’s premier GI conference.
27th May, 2025
Chinese MedTech Leader Highlights Inclusive Solutions and Global Collaboration at World Health Assembly Side Event
26th May, 2025
AI-Powered Risk Prediction Tool Enhances Early Detection of Cardiac Arrest, Advancing Critical Care Monitoring.
26th May, 2025
Meril’s groundbreaking trial demonstrates the efficacy and safety of the MGuard™ device, marking a major milestone in cardiovascular treatment and paving the way for improved patient outcomes worldwide
23rd May, 2025
New bioengineered device aims to transform treatment of peripheral nerve injuries with first-in-human evaluation now underway.
23rd May, 2025
New investment to accelerate global rollout of Koning’s 3D breast imaging technology.
23rd May, 2025
‘Neurophet AQUA AD’ demonstrates powerful clinical utility in early diagnosis and progression monitoring of Alzheimer’s disease.
22nd May, 2025
New clinical research aims to validate safety and effectiveness of low-radiation imaging in real-world cardiac interventions.
21st May, 2025
New device combines advanced imaging with artificial intelligence under a dual-brand strategy to enhance global eye care accessibility.
21st May, 2025
Company highlights AI-driven, scalable imaging solutions designed to improve access and clinical performance.
20th May, 2025
Revvity’s Diagnostics Arm Launches EUROLabWorkstation ELISA to Boost Specialty Lab Efficiency
20th May, 2025
Collaboration Aims to Improve Early Detection and Treatment Outcomes for Alzheimer’s Patients Across the U.S.
19th May, 2025
Breakthrough device-based therapies offer new hope for patients unresponsive to conventional treatments.
19th May, 2025
Despite being one of the most common neurological disorders worldwide, epilepsy continues to be misunderstood and stigmatized.
19th May, 2025
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer